Bloomage BioTechnology's solid financials and high ROE suggest a bright future, despite recent share price drop. Its efficient profit use and shareholder profit-sharing commitment are encouraging. Analysts predict continued earnings expansion.
Bloomage BioTechnology's high P/E ratio could face pressure due to weak earnings outlook and slower growth. Overly bullish investors refusing to sell at current prices may face future disappointment.
Core point 1. In the past three years, China's medical beauty industry has undergone earth-shaking changes, and non-surgical products occupy the mainstream 2. The brand is a marketing tool and a social contract for the legal entity to face society. Last year, it began to issue documents on supervising medical aesthetics, focusing on doctors' qualifications, marketing, and the capabilities of three types of ...
International beauty giants released their financial reports $L'OREAL (LRLCF.US)$$Estee Lauder (EL.US)$$Shiseido (ADR) (SSDOY.US)$ ①China's overall performance is poor, with only L'Oreal's positive growth, behind the reflection of organizational efficiency and brand matrix perfection differences. ②Effective skincare continues to overgrow, perfume demand explodes, and wash care upgrade is ready to take ...
2022 is a year full of variables in the beauty market. 1. Epidemic + consumption off-season National Bureau of Statistics January-November total cosmetics retail sales of 365.2 billion yuan, down 3.1% year-on-year, August-November is a continuous negative growth. Two landmark events in the year's first half, the ebb of beauty collection stores and the cold of 618, foreshadowed the standard pressure at...
Total Retail Sales of Consumer Goods: December 2022 total retail sales of consumer goods were 405.42 billion yuan, nominal -1.8% YoY (+4.1 pct from previous value), higher than expected, mainly due to the high increase in demand for drugs under the influence of the epidemic in December, as well as benefiting from the Spring Festival + subjective travel intentions to...
1
1
Report
pie pie
:
What should I do if I can't operate here at the opening of the domestic market
The COVID-19 infection rate has peaked in major Chinese cities (such as Beijing, Shanghai, Guangzhou, Shenzhen, and so on.) The number of COVID-19 infections has begun to fall from a high level. What is the progress of the current consumer market recovery now? How to grasp the investment opportunities in the consumer sector in 2023? [Food & Beauty]Infection peak has passed. Consumer recovery ahead Infections...
Bloomage Biotechnology Corporation Limited Stock Forum
1. In the past three years, China's medical beauty industry has undergone earth-shaking changes, and non-surgical products occupy the mainstream
2. The brand is a marketing tool and a social contract for the legal entity to face society. Last year, it began to issue documents on supervising medical aesthetics, focusing on doctors' qualifications, marketing, and the capabilities of three types of ...
$L'OREAL (LRLCF.US)$ $Estee Lauder (EL.US)$ $Shiseido (ADR) (SSDOY.US)$
①China's overall performance is poor, with only L'Oreal's positive growth, behind the reflection of organizational efficiency and brand matrix perfection differences.
②Effective skincare continues to overgrow, perfume demand explodes, and wash care upgrade is ready to take ...
1. Epidemic + consumption off-season
National Bureau of Statistics January-November total cosmetics retail sales of 365.2 billion yuan, down 3.1% year-on-year, August-November is a continuous negative growth.
Two landmark events in the year's first half, the ebb of beauty collection stores and the cold of 618, foreshadowed the standard pressure at...
How to grasp the investment opportunities in the consumer sector in 2023?
[Food & Beauty]Infection peak has passed. Consumer recovery ahead
Infections...
No comment yet